Display options
Share it on

Transfus Med Hemother. 2013 Oct;40(5):344-50. doi: 10.1159/000355519. Epub 2013 Sep 19.

Promoting Effects of Heparin on ex vivo Expansion of Megakaryocytopoiesis from Human Cord Blood CD34+ Cells.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Anne-Marie Maurer, Altay Gezer

Affiliations

  1. Department of Hematology, School of Medicine, Marmara University, Istanbul, Turkey.

PMID: 24273488 PMCID: PMC3822282 DOI: 10.1159/000355519

Abstract

INTRODUCTION: Transfusion of ex vivo expanded megakaryocytes (MKs) has been proposed to sustain platelet recovery after cord blood (CB) hematopoietic stem cell transplantation. In this study, we investigated the effects of heparin on ex vivo colony forming unit-megakaryocytes (CFU-MKs) and MKs expansion from CB CD34+ cells.

METHODS: CB CD34+ cells were stimulated by a combination of thrombopoietin (TPO), stem cell factor (SCF), Flt3-Ligand (FL), IL-6, and IL-11 supplemented with autologous serum and heparin during 14 days. Expanded cells were analyzed by flow cytometry and cultured in a CFU-MK assay.

RESULTS: Compared to control cultures, the 5-factor combination with heparin induced significantly (p ≤ 0.05) higher numbers of: CFU-MKs and CD41+ cells on days 7 and 14; CD41+ cells displaying hyperploidy levels (≥8N) on day 14; platelets on day 14. The culture-derived platelets were activated upon collagen stimulation.

CONCLUSION: Heparin can significantly enhance the stimulating effects of a combination of TPO, SCF, FL, IL-6, and IL-11 supplemented with autologous serum on CFU-MK, MK, and platelet production from CB CD34+ cells. This expansion system could represent a promising method to generate CFU-MKs and MKs cells for transfusion to sustain platelet reconstitution following CB transplantation.

Keywords: CD34+ cells; Cord blood; Expansion; Glycosaminoglycan; Megakaryocytopoiesis

References

  1. Methods Mol Biol. 2004;272:309-22 - PubMed
  2. Blood. 1998 Jun 1;91(11):4118-26 - PubMed
  3. Transfus Med Rev. 2010 Jan;24(1):33-43 - PubMed
  4. Prog Clin Biol Res. 1990;356:41-52 - PubMed
  5. J Thromb Haemost. 2003 Jul;1(7):1587-92 - PubMed
  6. Haematologica. 2006 Apr;91(4):445-51 - PubMed
  7. Blood. 2003 Jun 15;101(12):5061-7 - PubMed
  8. Cell Transplant. 2000 Jan-Feb;9(1):125-31 - PubMed
  9. Bone Marrow Transplant. 1999 Aug;24(4):397-403 - PubMed
  10. Hematology Am Soc Hematol Educ Program. 2009;:147-52 - PubMed
  11. Haematologica. 2000 Jan;85(1):25-30 - PubMed
  12. Nature. 1988 Mar 24;332(6162):376-8 - PubMed
  13. Science. 1996 Feb 23;271(5252):1116-20 - PubMed
  14. Nature. 1987 Mar 26-Apr 1;326(6111):403-5 - PubMed
  15. J Biomed Mater Res A. 2011 Mar 15;96(4):682-92 - PubMed
  16. Blood. 1990 Mar 15;75(6):1234-9 - PubMed
  17. Blood. 1998 Dec 15;92(12):4641-51 - PubMed
  18. Br J Haematol. 1994 Nov;88(3):608-12 - PubMed
  19. Exp Hematol. 2005 Dec;33(12):1537-43 - PubMed
  20. N Engl J Med. 1998 Nov 26;339(22):1565-77 - PubMed
  21. Semin Hematol. 2010 Jan;47(1):3-12 - PubMed
  22. Bone Marrow Transplant. 2000 Apr;25(7):797-9 - PubMed
  23. Blood. 1988 Mar;71(3):723-7 - PubMed
  24. Exp Hematol. 1995 Oct;23(11):1212-7 - PubMed
  25. Int J Hematol. 2000 Apr;71(3):203-10 - PubMed
  26. J Hematother Stem Cell Res. 2000 Aug;9(4):465-73 - PubMed
  27. J Cell Physiol. 1996 Jul;168(1):97-104 - PubMed
  28. Biol Blood Marrow Transplant. 2002;8(7):368-76 - PubMed
  29. Leukemia. 1988 Dec;2(12):804-9 - PubMed
  30. Nature. 1994 Jun 16;369(6481):533-8 - PubMed
  31. Experientia. 1995 Sep 29;51(9-10):914-26 - PubMed
  32. Bone Marrow Transplant. 1990 Feb;5(2):129-33 - PubMed
  33. Bone Marrow Transplant. 2008 May;41(9):771-8 - PubMed
  34. Blood. 1992 Aug 15;80(4):912-9 - PubMed

Publication Types